Your browser doesn't support javascript.
loading
Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2.
Tsutani, Yasuhiro; Goldman, Jonathan W; Dacic, Sanja; Yatabe, Yasushi; Majem, Margarita; Huang, Xiangning; Chen, Allen; van der Gronde, Toon; He, Jie.
Afiliação
  • Tsutani Y; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan. Electronic address: yatsutani@msn.com.
  • Goldman JW; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
  • Dacic S; Department of Pathology, Yale School of Medicine, New Haven, CT.
  • Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Huang X; Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom.
  • Chen A; Late Oncology Research & Development, AstraZeneca, New York, NY.
  • van der Gronde T; Late Oncology Research & Development, AstraZeneca, New York, NY.
  • He J; Thoracic Surgery Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Clin Lung Cancer ; 24(4): 376-380, 2023 06.
Article em En | MEDLINE | ID: mdl-36872181
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article